ART MEDICAL Ltd.
Yossi Hatan has extensive work experience in the financial sector. Yossi began their career at PwC, where they served as a Senior Manager for ten years. In 2016, they joined ART MEDICAL Ltd. as a VP Finance, and later that year, they also became a Co CEO at A2Z Finance Ltd. In 2019, Yossi joined Univo Pharmaceuticals as the VP of Finance. Currently, they hold the position of Chief Financial Officer at Unic-Tech, Limited Partnership, starting from July 2021. Overall, Yossi Hatan has a strong background in financial management and has held various leadership roles in reputable organizations.
Yossi Hatan's education history includes attending the Ruppin Academic Center. However, there is no information available regarding the years of attendance, degree obtained, or field of study.
This person is not in any offices
ART MEDICAL Ltd.
ART Medical was founded by inventor Liron Elia in 2009. The company offers a range of products that optimize enteral feeding as well as detect and prevent aspiration pneumonia, VAP and Acute Kidney Injury in critical care, ICU patients. The technology has received FDA approval and continue to grow its technology and work on clinical validations.The company based in Israel and Palo Alto.